Israel Active

The current 3-month SPARC training course for nurses at Israel’s Sheba Medical Center includes participants from Australia, Brazil, Germany, Japan, Nigeria, South Africa and the US. It selects innovative nurses who have ideas for life-saving solutions that they can develop into practice.

Haifa University governors laid the cornerstone of the Herta and Paul Amir School of Medicine. The 1,200-bed hospital is due to open in 2025, featuring state-of-the-art medical services; patient-centered care; hi-tech ICUs; and cardiovascular, thoracic, and surgical oncology departments.

Israel’s Air Doctor (see previously) now has 20,000 doctors registered to its service globally, partnering with insurance companies in 80 countries. It has also added video telemedicine consultations on their platform and reduced insurance claim costs by 54%.

The French-based Human Frontier Science Program (HFSP) funds basic research in life sciences. It has awarded a $1.2 million grant to Ben Gurion University Prof Michael Meijler to investigate how certain gut bacteria affect human behavior, such as anxiety and stress.

A detailed article about Israel’s Remepy (see previously). It has completed three clinical trials involving 200 patients, using its digital molecules to treat cancer, MCI (Mild Cognitive Impairment) and Parkinson’s. It aims to bring its first product to market within three years.  

In Nov 2023, Olessia Kantor founded Israel’s Lev Esh (Fire Heart) project to address the mental health crisis that has intensified since Oct 7. Lev Esh serves as a vital lifeline, connecting trauma sufferers with a network of practitioners, including psychologists, psychiatrists, and holistic therapists.   (In Hebrew only)

Israel’s RevitalVision (see previously) has been very successful in improving the condition of the visually impaired. On average, the structured on-line brain exercises achieve a measurable improvement of 20 – 25%, equivalent to an extra two lines on a standard eye chart.

The nano-platform technology of Israel’s NanoCarry traverses the Blood Brain Barrier (BBB) to deliver potentially life-saving therapies to the brain.  Its initial target is HER2 breast cancer brain metastases for which there is no treatment, even though the original cancer can now effectively be cured.

Doctors saved an Israeli woman in her 50s after she was bitten by a snake in southern Israel. She was brought to Ashdod hospital by family members who also brought the snake.  Doctors were able to identify the snake and administer the correct anti-venom serum.  The article contains some important advice.

The US FDA has extended its approval of the Deep Transcranial Magnetic Stimulation system from Israel’s BrainsWay (see previously). It can now be used to treat depression up to the patient’s 86th birthday. The previous maximum age limit was 67.